Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06157164 · ClinicalTrials.gov registry record
IIT-2022-Simultaneous Urolift™ and Median Lobe Enucleation
A clinical trial, sponsored by University of Kansas Medical Center.
- Terminated
- Registry status
- 3
- Enrollment target
NCT06157164: Clinical Trial study, sponsored by University of Kansas Medical Center.
NCT06157164 is a clinical trial that was terminated before completion, run by University of Kansas Medical Center. The registered enrollment target is 3 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06157164 was terminated before completion, sponsored by University of Kansas Medical Center.
- TERMINATED
- Registry status
- 3 participants
- Enrollment target
Study Summary
To evaluate postoperative outcomes of BPH/Lower urinary tract symptoms, erectile function, and ejaculatory capacity of simultaneous UroLiftTM and Holmium laser enucleation of the prostatic median lobe.
Primary Outcome
To evaluate improvement of symptoms through the International Prostate Symptom Score (IPSS) change (improvement) from baseline at 3 and 12 months. The IPSS is an 8-question screening tool used to screen for, rapidly diagnose, track the symptoms of, and suggest management of the symptoms of the disease benign prostatic hyperplasia (BPH). Scoring: 0-7 Mildly symptomatic 8-19 Moderately symptomatic 20-35 Severely symptomatic
Interventions
- OTHER UroLift™ System and Holmium Laser Enucleation of the Prostate (HoLEP)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2023-02-06 |
| Est. Completion | 2025-01-14 |
Why NCT06157164 stopped before completion
NCT06157164 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 3 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which UroLift™ System and Holmium Laser Enucleation of the Prostate (HoLEP) is the first listed.
NCT06157164 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06157164 about?
NCT06157164 is a clinical study titled "IIT-2022-Simultaneous Urolift™ and Median Lobe Enucleation". To evaluate postoperative outcomes of BPH/Lower urinary tract symptoms, erectile function, and ejaculatory capacity of simultaneous UroLiftTM and Holmium laser enucleation of the prostatic median lobe.
What is the current status of trial NCT06157164?
This trial is currently terminated. The enrollment target is 3 participants. The study started on 2023-02-06. Estimated completion is 2025-01-14.
What interventions are being tested in trial NCT06157164?
The interventions under investigation include: UroLift™ System and Holmium Laser Enucleation of the Prostate (HoLEP) (OTHER).
Who is sponsoring clinical trial NCT06157164?
This trial is sponsored by University of Kansas Medical Center, which has 408 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI